Chugai Pharmaceutical Co., Ltd.
CHGCYOTCHealthcare● Active
$23.50
+$0.44(+1.91%)
Market Cap$77.4B
P/E Ratio—
52W High$34.84
52W Low$19.5
Chugai Pharmaceutical Co., Ltd.（CHGCY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CHGCY · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.319T | $1.171T | $1.111T | $1.260T | $1.000T |
| Cost of Revenue | $0.381T | $0.339T | $0.413T | $0.476T | $0.338T |
| Gross Profit | $0.938T | $0.831T | $0.698T | $0.784T | $0.662T |
| Gross Margin %(computed) | 71.09% | 71.01% | 62.81% | 62.20% | 66.18% |
| Operating Expenses | |||||
| R&D Expenses | $0.197T | $0.181T | $0.175T | $0.150T | $0.137T |
| G&A Expenses | $0.000T | $0.000T | $0.000T | $0.024T | $0.026T |
| Total Operating Expenses | $0.319T | $0.289T | $0.259T | $0.250T | $0.240T |
| Operating Income | $0.619T | $0.542T | $0.439T | $0.533T | $0.422T |
| Operating Margin %(computed) | 46.92% | 46.30% | 39.52% | 42.33% | 42.20% |
| Interest Income | $0.004T | $0.000T | $0.005T | $0.000T | $0.000T |
| Interest Expense | $0.001T | ($0.001T) | $0.000T | $0.000T | $0.000T |
| Income Before Tax | $0.627T | $0.543T | $0.444T | $0.531T | $0.419T |
| Income Tax Expense | $0.172T | $0.156T | $0.118T | $0.157T | $0.116T |
| Net Income | $0.455T | $0.387T | $0.325T | $0.374T | $0.303T |
| Net Margin %(computed) | 34.50% | 33.09% | 29.29% | 29.72% | 30.31% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $138.26 | $117.70 | $98.90 | $113.82 | $92.15 |
| Wtd Avg Shares | 0.003T | 0.003T | 0.003T | 0.003T | 0.003T |
| EBITDA | $0.662T | $0.574T | $0.471T | $0.565T | $0.450T |
| EBITDA Margin %(computed) | 50.19% | 49.01% | 42.37% | 44.82% | 45.04% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · JPY · T
深入了解Chugai Pharmaceutical Co., Ltd.
关于Chugai Pharmaceutical Co., Ltd.（CHGCY）损益表
Chugai Pharmaceutical Co., Ltd.（CHGCY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CHGCY实现营收$1318.93B，毛利润$937.60B（毛利率71.09%），净利润$455.05B（净利率34.50%）。
常见问题
CHGCY · 4 问Chugai Pharmaceutical Co., Ltd.（CHGCY）2025财年营收为$1318.93B，同比up12.7%。
CHGCY revenueCHGCY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09